Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AGILeBiotics B.V. logo — We are passionately translating innovation into novel antibi...

AGILeBiotics B.V.

We are passionately translating innovation into novel antibiotics for the treatment of multidrug-resistant infections!

Founded 2017 The Netherlands The Netherlands 1 employees Seed Biotechnology, Health Care +1

General Information

Company Name AGILeBiotics B.V.
Founded Year 2017
Location The Netherlands The Netherlands +1
Employees 1
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Seed
Social

Get notified when AGILeBiotics B.V. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AGILeBiotics B.V.

AGILeBiotics B.V., a spin-off from University of Groningen, is at the forefront of biotechnology and healthcare, focusing on the critical field of antibiotic research. Founded in 2017, the company is strategically located in the Innolab Chemie Groningen in The Netherlands.

The company is passionate about translating innovation into novel antibiotics, aiming to combat the urgent global challenge of multidrug-resistant infections. Collaborating with regional and international partners, AGILeBiotics B.V. harnesses natural products to develop its next-generation antibiotics.

Their slogan, "We are passionately translating innovation into novel antibiotics for the treatment of multidrug-resistant infections!", encapsulates their mission-driven approach. Initially backed by a Seed Round investment on 01 March 2017, key investors include RUG Holding and GJ Smid Fonds.

Taxonomy: antibiotic development, multidrug-resistant infections, pharmaceutical research, natural product-based antibiotics, lead optimization, drug discovery, antibacterial research, selective modification, life-threatening infections, hospital-acquired infections, early-stage pharmaceutical

Services & Products

Category search engine
Information aggregation
User-focused content navigation

Target Customers

Consumers seeking categorized content Individuals interested in diverse sectors like automotive and health Online shoppers Travel enthusiasts

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 2
Investor Investor
01 Mar 2017

AGILeBiotics B.V. Alternatives & Competitors

AGILeBiotics B.V. vs
Fimbrion Therapeutics, Inc.
Fimbrion Therapeutics, Inc. United States

Antibiotic-sparing approaches to fight acute and resistant infections caused by bacteria and other p...

6 employees
Health Care
AGILeBiotics B.V. vs
SelectX Pharmaceuticals
SelectX Pharmaceuticals United States

SelectX Pharmaceuticals is a biopharmaceutical company that focuses on the discovery and development...

Series B
6 employees
Biotechnology, Health Care
AGILeBiotics B.V. vs
Signia Therapeutics
Signia Therapeutics France

Breakthrough Solution for Respiratory Infections

Grant
6 employees

FAQ About AGILeBiotics B.V.

We are passionately translating innovation into novel antibiotics for the treatment of multidrug-resistant infections!
AGILeBiotics B.V. was founded in 2017.
AGILeBiotics B.V. is headquartered in The Netherlands.
AGILeBiotics B.V. operates in the following industries: Biotechnology, Health Care, Health and Wellness.
AGILeBiotics B.V. has approximately 1 employees.
AGILeBiotics B.V. has completed 1 funding round. The latest funding stage is Seed.
AGILeBiotics B.V. offers: Category search engine, Information aggregation, User-focused content navigation.
Top alternatives and competitors to AGILeBiotics B.V. include Fimbrion Therapeutics, Inc., SelectX Pharmaceuticals, Signia Therapeutics, Arpida, Venatorx Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AGILeBiotics B.V. and Fimbrion Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AGILeBiotics B.V. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy